Goda Lab reaches final phase of XPRIZE healthspan competition as milestone 2 awardee with breakthrough super exosomes
Grant and Award Announcement
Updates every hour. Last Updated: 28-Oct-2026 19:16 ET (28-Oct-2026 23:16 GMT/UTC)
Researchers at the Icahn School of Medicine at Mount Sinai are among the Milestone 2 Awardee teams in XPRIZE Healthspan, a $101 million global competition that challenges researchers to develop new approaches that help people live healthier, longer lives. XPRIZE Healthspan is a 7-year global competition incentivizing teams to develop and test therapeutics that restore muscle, cognition, and immune function in adults aged 50 to 90 by a minimum of 10 years, with an ambitious goal of 20 years, to extend healthy life within one year or less of treatment. After emerging from an international field of semifinalists announced in May 2025, Mount Sinai’s NYC-Vita clinical trial team was selected as a Milestone 2 Award recipient, advancing to the XPRIZE Healthspan Finals and receiving $1 million for its evidence-based approach to extending healthy aging.
The University of Louisville has received a new federal designation and funding for its physician-scientist training program, placing it among top MD-PhD training programs across the U.S. The designation will enable the UofL School of Medicine to amplify the program’s curriculum and increase the number of physician-researchers trained to bridge laboratory research and patient care.
A new study suggests the mental health benefits often associated with religiosity may be attributed to the the habits and mindset it encourages.
Researchers found that a stronger sense of purpose, healthier digital habits, and less exposure to harmful online content were the strongest predictors of lower risk for addiction, anxiety, depression, and PTSD.